Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) PS Ratio: 4.75

Is Stryker Corporation’s P/S ratio high or low?

Stryker Corporation's P/S ratio of 4.75 is 19% below its 5-year average of 5.84, near the low end of its 5-year range (4.16–7.02).

As of Wednesday, June 17, 2026. 16.84% below its 12-month average of 5.71.

SYK PS Ratio Chart

SYK PS Ratio
4.75-24.36% 1Y
Zoom

SYK Average PS Ratio Chart

SYK Current vs Average PS Ratio Chart

SYK PS Ratio Metrics

PS RATIO

4.75

PS RATIO AVG TTM

5.71

PS RATIO AVG 3Y

6.04

PS RATIO AVG 5Y

5.84

PS RATIO AVG 10Y

5.46

PS RATIO AVG 15Y

4.69

PS RATIO AVG 20Y

4.43

CURRENT VS TTM AVG

-16.84%

CURRENT VS 3Y AVG

-21.35%

CURRENT VS 5Y AVG

-18.73%

CURRENT VS 10Y AVG

-12.95%

CURRENT VS 15Y AVG

+1.27%

CURRENT VS 20Y AVG

+7.27%

SYK Competitors' PS Ratio

NAMEMARKET CAPPS RATIOTTM3Y5Y
Stryker Corporation (SYK)$119.06B4.755.716.045.84
Bristol-Myers Squibb Company (BMY)vs ›$114.38B2.372.222.302.70
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$113.82B9.429.6610.549.74
CVS Health Corporation (CVS)vs ›$127.54B0.320.250.240.31
Danaher Corporation (DHR)vs ›$128.72B5.206.016.596.42
Medtronic plc (MDT)vs ›$104.05B2.853.413.423.78
Intuitive Surgical, Inc. (ISRG)vs ›$148.26B14.1618.6319.8718.99
Pfizer Inc. (PFE)vs ›$148.76B2.352.322.452.86
HCA Healthcare, Inc. (HCA)vs ›$88.05B1.181.421.321.29
Elevance Health Inc. (ELV)vs ›$86.74B0.440.390.550.64

P/S vs. its own history

At 4.75, P/S is in its normal range, sitting higher than 56% of its 20-year history.

20-year low

1.85

median

4.48

20-year high

7.09

cheaperricher

Sales Valuation

P/S Ratio

4.75

Market Cap / Annual Revenue

Stryker Corporation PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Stryker Corporation PS Ratio FAQ

What is the P/S ratio for Stryker Corporation (SYK)?
The P/S ratio for SYK stock is 4.75.
Is Stryker Corporation's P/S ratio high or low?
Stryker Corporation's P/S ratio of 4.75 is 19% below its 5-year average of 5.84, near the low end of its 5-year range (4.16–7.02).
What is the TTM average P/S ratio for Stryker Corporation (SYK)?
The TTM average P/S ratio for SYK stock is 5.71.
What is the 3Y average P/S ratio for Stryker Corporation (SYK)?
The 3Y average P/S ratio for SYK stock is 6.04.
What is the 5Y average P/S ratio for Stryker Corporation (SYK)?
The 5Y average P/S ratio for SYK stock is 5.84.
What is the 10Y average P/S ratio for Stryker Corporation (SYK)?
The 10Y average P/S ratio for SYK stock is 5.46.
What is the 15Y average P/S ratio for Stryker Corporation (SYK)?
The 15Y average P/S ratio for SYK stock is 4.69.
What is the 20Y average P/S ratio for Stryker Corporation (SYK)?
The 20Y average P/S ratio for SYK stock is 4.43.

Stryker Corporation PS Ratio History

DATEPS RATIO
2026-06-164.75
2026-06-154.71
2026-06-124.78
2026-06-114.67
2026-06-104.72
2026-06-094.80
2026-06-084.61
2026-06-054.68
2026-06-044.61
2026-06-034.51
2026-06-024.49
2026-06-014.58
2026-05-294.67
2026-05-284.71
2026-05-274.68
2026-05-264.79
2026-05-224.84
2026-05-214.79
2026-05-204.92
2026-05-194.86
2026-05-184.79
2026-05-154.69
2026-05-144.67
2026-05-134.62
2026-05-124.50
2026-05-114.32
2026-05-084.39
2026-05-074.53
2026-05-064.50
2026-05-054.54
2026-05-044.48
2026-05-014.54
2026-04-304.85
2026-04-294.85
2026-04-284.95
2026-04-275.06
2026-04-245.04
2026-04-235.07
2026-04-225.07
2026-04-215.04
2026-04-205.21
2026-04-175.28
2026-04-165.21
2026-04-155.25
2026-04-145.32
2026-04-135.34
2026-04-105.22
2026-04-095.22
2026-04-085.23
2026-04-075.11
2026-04-065.11
2026-04-025.10
2026-04-015.07
2026-03-315.06
2026-03-305.02
2026-03-275.04
2026-03-265.12
2026-03-255.04
2026-03-245.06
2026-03-235.12
2026-03-205.17
2026-03-195.23
2026-03-185.32
2026-03-175.37
2026-03-165.38
2026-03-135.18
2026-03-125.19
2026-03-115.32
2026-03-105.52
2026-03-095.63
2026-03-065.61
2026-03-055.70
2026-03-045.88
2026-03-035.92
2026-03-025.96
2026-02-275.96
2026-02-265.94
2026-02-255.91
2026-02-245.87
2026-02-235.92
2026-02-205.85
2026-02-195.73
2026-02-185.81
2026-02-175.68
2026-02-135.63
2026-02-125.63
2026-02-115.60
2026-02-105.73
2026-02-095.65
2026-02-065.68
2026-02-055.75
2026-02-045.72
2026-02-035.72
2026-02-025.84
2026-01-305.86
2026-01-295.62
2026-01-285.68
2026-01-275.62
2026-01-265.66
2026-01-235.63
2026-01-225.69
2026-01-215.76
2026-01-205.70
2026-01-165.77
2026-01-155.75
2026-01-145.70
2026-01-135.64
2026-01-125.73
2026-01-095.83
2026-01-085.82
2026-01-075.83
2026-01-065.81
2026-01-055.53
2026-01-025.52
2025-12-315.57
2025-12-305.62
2025-12-295.59
2025-12-265.62
2025-12-245.63
2025-12-235.63
2025-12-225.65
2025-12-195.63
2025-12-185.60
2025-12-175.59
2025-12-165.58
2025-12-155.64
2025-12-125.62
2025-12-115.60
2025-12-105.61
2025-12-095.54
2025-12-085.61
2025-12-055.77
2025-12-045.78
2025-12-035.80
2025-12-025.82
2025-12-015.91
2025-11-285.89
2025-11-265.90
2025-11-255.95
2025-11-245.87
2025-11-215.84
2025-11-205.72
2025-11-195.78
2025-11-185.70
2025-11-175.71
2025-11-145.75
2025-11-135.92
2025-11-125.83
2025-11-115.77
2025-11-105.63
2025-11-075.65
2025-11-065.61
2025-11-055.67
2025-11-045.75
2025-11-035.68
2025-10-315.65
2025-10-305.99
2025-10-296.00
2025-10-286.10
2025-10-276.23
2025-10-246.19
2025-10-236.21
2025-10-226.30
2025-10-216.16
2025-10-206.18
2025-10-176.07
2025-10-165.99
2025-10-156.00
2025-10-146.00
2025-10-135.92
2025-10-105.91
2025-10-096.01
2025-10-086.09
2025-10-075.99
2025-10-065.94
2025-10-036.01
2025-10-025.94
2025-10-015.91
2025-09-306.00
2025-09-296.00
2025-09-265.99
2025-09-255.98
2025-09-246.02
2025-09-236.06
2025-09-226.14
2025-09-196.11
2025-09-186.13
2025-09-176.11
2025-09-166.11
2025-09-156.12
2025-09-126.22
2025-09-116.31
2025-09-106.21
2025-09-096.37
2025-09-086.38
2025-09-056.36
2025-09-046.40
2025-09-036.30
2025-09-026.33
2025-08-296.35
2025-08-286.32
2025-08-276.38
2025-08-266.40
2025-08-256.34
2025-08-226.40
2025-08-216.24
2025-08-206.36
2025-08-196.33
2025-08-186.19
2025-08-156.20
2025-08-146.14
2025-08-136.15
2025-08-126.11
2025-08-116.11
2025-08-086.13
2025-08-076.11
2025-08-066.08
2025-08-056.18
2025-08-046.19
2025-08-016.13
2025-07-316.54
2025-07-306.66
2025-07-296.67
2025-07-286.67
2025-07-256.72
2025-07-246.60
2025-07-236.67
2025-07-226.58
2025-07-216.45
2025-07-186.48
2025-07-176.47
2025-07-166.50
2025-07-156.50
2025-07-146.51
2025-07-116.48
2025-07-106.57
2025-07-096.52
2025-07-086.48
2025-07-076.53
2025-07-036.58
2025-07-026.52
2025-07-016.60
2025-06-306.58
2025-06-276.55
2025-06-266.50
2025-06-256.53
2025-06-246.43
2025-06-236.31
2025-06-206.25
2025-06-186.21
2025-06-176.21
2025-06-166.28
2025-06-136.28
2025-06-126.33
2025-06-116.34
2025-06-106.41
2025-06-096.36
2025-06-066.39
2025-06-056.38
2025-06-046.37

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo